alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# L_2008182EN.01000901.xml

| 10.7.2008 | EN | Official Journal of the European Union | L 182/9 |
| --- | --- | --- | --- |

10.7.2008

EN

Official Journal of the European Union

L 182/9

---

DECISION OF THE EEA JOINT COMMITTEE

No 24/2008

of 14 March 2008

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area, as amended by the Protocol adjusting the Agreement on the European Economic Area, hereinafter referred to as ‘the Agreement’, and in particular Article 98 thereof,

Whereas:

| (1) | Annex II to the Agreement was amended by Decision of the EEA Joint Committee No 8/2008 of 1 February 2008 (1). |
| --- | --- |

(1)

Annex II to the Agreement was amended by Decision of the EEA Joint Committee No 8/2008 of 1 February 2008 (1).

| (2) | Commission Decision 2007/565/EC of 14 August 2007 concerning the non-inclusion in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market of certain substances to be examined under the 10-year work programme referred to in Article 16(2) thereof (2) is to be incorporated into the Agreement, |
| --- | --- |

(2)

Commission Decision 2007/565/EC of 14 August 2007 concerning the non-inclusion in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market of certain substances to be examined under the 10-year work programme referred to in Article 16(2) thereof (2) is to be incorporated into the Agreement,

HAS DECIDED AS FOLLOWS:

Article 1

The following point shall be inserted after point 12za (Commission Decision 2007/639/EC) of Chapter XV of Annex II to the Agreement:

| ‘12zb. | 32007 D 0565: Commission Decision 2007/565/EC of 14 August 2007 concerning the non-inclusion in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market of certain substances to be examined under the 10-year work programme referred to in Article 16(2) thereof (OJ L 216, 21.8.2007, p. 17).’ |
| --- | --- |

‘12zb.

Article 2

The texts of Decision 2007/565/EC in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 15 March 2008, provided that all the notifications under Article 103(1) of the Agreement have been made to the EEA Joint Committee (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 14 March 2008.

For the EEA Joint Committee

The President

Alan SEATTER

---

(1)  
  OJ L 154, 12.6.2008, p. 15.

1

(2)  
  OJ L 216, 21.8.2007, p. 17.

2

(*1)  No constitutional requirements indicated.

*1

---
<PAGE>

                                                                    EXHIBIT 99.1

                              BGF Industries, Inc.
                     Reconciliation of Net Income to EBITDA
                             (dollars in thousands)

<TABLE>
<CAPTION>
                                                      Fiscal Year Ended December 31,
                                     ---------------------------------------------------------
                                         2002        2001        2000       1999      1998
                                     -----------  ----------  ---------  ---------  ----------
<S>                                  <C>          <C>         <C>        <C>        <C>
Net income (loss)                    $  (140,573) $   (3,078) $   8,330  $   3,688  $   15,317
Depreciation and amortization             12,966       8,744      8,584      8,206       7,399
Interest                                  13,926      13,972     14,168     15,817       4,517
Taxes                                      6,835      (1,868)     5,602      2,241       9,854
Extraordinary loss                            --          --         --      1,668          --
Non-cash non-recurring charges:
    Reserve on loan to parent             97,711          --         --         --          --
    Asset impairment charge                5,816          --         --         --          --
    Retirement settlement charge           1,386          --         --         --          --
                                     -----------  ----------  ---------  ---------  ----------
EBITDA                               $    (1,933) $   17,770  $  36,684  $  31,620  $   37,087
                                     ===========  ==========  =========  =========  ==========
</TABLE>
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>                     <C>
<PERIOD-TYPE>                   YEAR                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998             DEC-31-1999
<PERIOD-START>                             JAN-01-1998             JAN-01-1999
<PERIOD-END>                               DEC-31-1998             DEC-31-1999
<CASH>                                         232,073              55,524,189
<SECURITIES>                                         0               1,968,203
<RECEIVABLES>                                        0               7,020,256
<ALLOWANCES>                                         0                 493,992
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                               232,073              70,788,329
<PP&E>                                          54,733               5,926,389
<DEPRECIATION>                                   8,505                 546,397
<TOTAL-ASSETS>                                 278,301              76,857,184
<CURRENT-LIABILITIES>                          477,340              10,159,555
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                        2,023,375                       0
<PREFERRED>                                          0                       0
<COMMON>                                        32,750                 202,990
<OTHER-SE>                                 (2,255,164)              65,473,947
<TOTAL-LIABILITY-AND-EQUITY>                   278,301              76,857,184
<SALES>                                         56,750              14,019,485
<TOTAL-REVENUES>                                56,750              14,019,485
<CGS>                                           59,472                 965,711
<TOTAL-COSTS>                                   59,472                 965,711
<OTHER-EXPENSES>                             1,968,999              45,192,420
<LOSS-PROVISION>                                     0                 493,992
<INTEREST-EXPENSE>                                   0                  30,771
<INCOME-PRETAX>                            (1,947,206)            (31,609,522)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                        (1,947,206)            (31,609,522)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                               (1,947,206)            (31,609,522)
<EPS-BASIC>                                     (0.64)                  (6.26)
<EPS-DILUTED>                                   (0.64)                  (6.26)


</TABLE>
```
 
 
NATURAL GAS ICE HENRY HUB - ICE OTC                                  Code-023391
FUTURES ONLY POSITIONS AS OF 04/20/10                         |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  LONG  | SHORT  |SPREADS |  LONG  | SHORT  |  LONG  | SHORT  |  LONG  | SHORT
--------------------------------------------------------------------------------
(Contracts of 2,500  MMBTU'S)                        OPEN INTEREST:    4,142,564
COMMITMENTS
 518,322   71,101  1345922  2257503  2717115  4121747  4134138   20,817    8,426

CHANGES FROM 04/13/10 (CHANGE IN OPEN INTEREST:     56,252)
  -4,356    3,191   62,377    2,409       36   60,430   65,604   -4,178   -9,352

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADERS
    12.5      1.7     32.5     54.5     65.6     99.5     99.8      0.5      0.2

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:      212)
      44       31       71      131      123      204      196
```

----

Updated April 28, 2010
Robert W. CRONIN, petitioner, v. Julie L. JONES, Secretary, Florida Department of Corrections, et al.

No. 17-6000.

Supreme Court of the United States

Nov. 13, 2017.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>                         0001079110
<NAME>                        Via Vid
<MULTIPLIER>                                   1
<CURRENCY>                                     U.S. Dollars

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                              MAR-31-2000
<PERIOD-START>                                 APR-01-1999
<PERIOD-END>                                   MAR-31-2000
<EXCHANGE-RATE>                                1.000
<CASH>                                         134,540
<SECURITIES>                                   0
<RECEIVABLES>                                  6,164
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               153,749
<PP&E>                                         217,854
<DEPRECIATION>                                 34,114
<TOTAL-ASSETS>                                 337,489
<CURRENT-LIABILITIES>                          49,574
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       6,652
<OTHER-SE>                                     281,263
<TOTAL-LIABILITY-AND-EQUITY>                   337,489
<SALES>                                        50,148
<TOTAL-REVENUES>                               50,148
<CGS>                                          1,055,249
<TOTAL-COSTS>                                  1,055,249
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                (1,005,146)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (1,005,146)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (1,005,146)
<EPS-BASIC>                                    (0.16)
<EPS-DILUTED>                                  (0.16)



</TABLE>
# C_2016310EN.01000101.xml

| 25.8.2016 | EN | Official Journal of the European Union | C 310/1 |
| --- | --- | --- | --- |

25.8.2016

EN

Official Journal of the European Union

C 310/1

---

EUROPEAN PARLIAMENT

EUROPEAN PARLIAMENT

2014-2015 SESSION

Sittings of 9 to 12 February 2015

The Minutes of this session have been published in

  OJ C 102, 17.3.2016
  .

The Minutes of this session have been published in

OJ C 102, 17.3.2016

TEXTS ADOPTED

---
David Christopher HESSE, petitioner, v. TEXAS.

No. 16-1316.

Supreme Court of the United States

Oct. 2, 2017.

Petition for writ of certiorari to the Court of Appeals of Texas, First District denied.
Exhibit 32.2



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Indevus Pharmaceuticals, Inc. (the Company) on Form 10-Q for the period ended June 30, 2004 as
filed with the Securities and Exchange Commission on the date hereof (the Report), I, Michael W. Rogers, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the
Sarbanes-Oxley Act of 2002, that to the best of my knowledge: (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in
all material respects, the financial condition and result of operations of the Company.



|    |  |                        
|--- |  | -----------------------
|By: |  | /s/ Michael W. Rogers  
|    |  | Chief Financial Officer
|    | 
|    |  | August 16, 2004
[Federal Register Volume 87, Number 80 (Tuesday, April 26, 2022)]
[Notices]
[Pages 24624-24639]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-08821]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY

Office of Foreign Assets Control


Notice of OFAC Sanctions Actions

AGENCY: Office of Foreign Assets Control, Treasury.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The U.S. Department of the Treasury's Office of Foreign Assets 
Control (OFAC) is publishing the names of one or more persons that have 
been placed on OFAC's Specially Designated Nationals and Blocked 
Persons List based on OFAC's determination that one or more applicable 
legal criteria were satisfied. All property and interests in property 
subject to U.S. jurisdiction of these persons are blocked, and U.S. 
persons are generally prohibited from engaging in transactions with 
them.

DATES: See SUPPLEMENTARY INFORMATION section for effective date(s).

FOR FURTHER INFORMATION CONTACT: OFAC: Andrea Gacki, Director, tel.: 
202-622-2490; Associate Director for Global Targeting, tel.: 202-622-
2420; Assistant Director for Licensing, tel.: 202-622-2480; Assistant 
Director for Regulatory Affairs, tel.: 202-622-4855; or the Assistant 
Director for Sanctions

[[Page 24625]]

Compliance & Evaluation, tel.: 202-622-2490.

SUPPLEMENTARY INFORMATION: 

Electronic Availability

    The Specially Designated Nationals and Blocked Persons List and 
additional information concerning OFAC sanctions programs are available 
on OFAC's website (https://www.treasury.gov/ofac).

Notice of OFAC Actions

    On April 20, 2022, OFAC determined that the property and interests 
in property subject to U.S. jurisdiction of the following persons are 
blocked under the relevant sanctions authority listed below.
BILLING CODE 4810-AL-P
[GRAPHIC] [TIFF OMITTED] TN26AP22.060


[[Page 24626]]


[GRAPHIC] [TIFF OMITTED] TN26AP22.061


[[Page 24627]]


[GRAPHIC] [TIFF OMITTED] TN26AP22.062


[[Page 24628]]


[GRAPHIC] [TIFF OMITTED] TN26AP22.063


[[Page 24629]]


[GRAPHIC] [TIFF OMITTED] TN26AP22.064


[[Page 24630]]


[GRAPHIC] [TIFF OMITTED] TN26AP22.065


[[Page 24631]]


[GRAPHIC] [TIFF OMITTED] TN26AP22.066


[[Page 24632]]


[GRAPHIC] [TIFF OMITTED] TN26AP22.067


[[Page 24633]]


[GRAPHIC] [TIFF OMITTED] TN26AP22.068


[[Page 24634]]


[GRAPHIC] [TIFF OMITTED] TN26AP22.069


[[Page 24635]]


[GRAPHIC] [TIFF OMITTED] TN26AP22.070


[[Page 24636]]


[GRAPHIC] [TIFF OMITTED] TN26AP22.071


[[Page 24637]]


[GRAPHIC] [TIFF OMITTED] TN26AP22.072


[[Page 24638]]


[GRAPHIC] [TIFF OMITTED] TN26AP22.073


[[Page 24639]]


[GRAPHIC] [TIFF OMITTED] TN26AP22.074


    Dated: April 20, 2022.
Andrea M. Gacki,
Director, Office of Foreign Assets Control, U.S. Department of the 
Treasury.
[FR Doc. 2022-08821 Filed 4-25-22; 8:45 am]
BILLING CODE 4810-AL-C
116TH CONGRESS 

1ST SESSION H. R. 450 

AN ACT 

To amend title 18, United States Code, to provide an additional tool to prevent certain frauds against veterans, 

and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2 

•HR 450 EH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Preventing Crimes 

3 Against Veterans Act of 2019’’. 

4 SEC. 2. ADDITIONAL TOOL TO PREVENT CERTAIN FRAUDS 

5 AGAINST VETERANS. 

6 (a) IN GENERAL.—Chapter 63 of title 18, United 

7 States Code, is amended by adding at the end the fol8 lowing: 

9 ‘‘§ 1352. Fraud regarding veterans’ benefits 

10 ‘‘(a) Whoever knowingly executes, or attempts to exe11 cute, any scheme or artifice to defraud an individual of 

12 veterans’ benefits, or in connection with obtaining vet13 eran’s benefits for that individual, shall be fined under this 

14 title, imprisoned not more than 5 years, or both. 

15 ‘‘(b) In this section— 

16 ‘‘(1) the term ‘veteran’ has the meaning given 

17 that term in section 101 of title 38; and 

18 ‘‘(2) the term ‘veterans’ benefits’ means any 

19 benefit provided by Federal law for a veteran or a 

20 dependent or survivor of a veteran.’’. 

21 (b) CLERICAL AMENDMENT.—The table of sections 

22 at the beginning of chapter 63 of title 18, United States 

23 Code, is amended by adding at the end the following new 

24 item: 

‘‘1352. Fraud regarding veterans’ benefits.’’. 
3 

•HR 450 EH

1 SEC. 3. DETERMINATION OF BUDGETARY EFFECTS. 

2 The budgetary effects of this Act, for the purpose of 

3 complying with the Statutory Pay-As-You-Go Act of 2010, 

4 shall be determined by reference to the latest statement 

5 titled ‘‘Budgetary Effects of PAYGO Legislation’’ for this 

6 Act, submitted for printing in the Congressional Record 

7 by the Chairman of the House Budget Committee, pro8 vided that such statement has been submitted prior to the 

9 vote on passage. 

Passed the House of Representatives February 7, 

2019. 

Attest: 

Clerk. 
116TH CONGRESS 

1ST SESSION H. R. 450 

AN ACT 

To amend title 18, United States Code, to provide 

against veterans, and for other purposes. an additional tool to prevent certain frauds
Olufemi S. COLLINS, et ux., petitioners, v. JPMORGAN CHASE BANK, N.A., et al.

No. 17-5691.

Supreme Court of the United States

Dec. 11, 2017.

Petition for rehearing denied.
EXHIBIT 31.2
IEA Income Fund X, L.P.
RULE 13a-14 CERTIFICATION
     I, John Kallas, certify that:
     1. I have reviewed this quarterly report on Form 10-Q of IEA Income FundX, L.P. (the “Registrant”);
     2. Based on my knowledge, this quarterly report does not contain anyuntrue statement of a material fact or omit to state a material fact necessaryto make the statements made, in light of the circumstances under which suchstatements were made, not misleading with respect to the period covered by thisquarterly report;
     3. Based on my knowledge, the financial statements, and other financialinformation included in this quarterly report, fairly present in all materialrespects the financial condition, results of operations and cash flows of theRegistrant as of, and for, the periods presented in this quarterly report;
     4. The other certifying officer of Cronos Capital Corp. (“CCC”), theGeneral Partner of the Registrant, and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange ActRules 13a-15(e) and 15d-15(e)) for the Registrant and we have:
          (a) designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under our supervision, toensure that material information relating to the Registrant, including itsconsolidated subsidiaries, is made known to us by others within those entities,particularly during the period in which this quarterly report is beingprepared; and
          (b) evaluated the effectiveness of the Registrant’s disclosure controlsand procedures and presented in this report our conclusions about theeffectiveness of the disclosure controls and procedures, based on ourevaluation; and
          (c) disclosed in this report any change in the Registrant’s internalcontrol over financial reporting that occurred during the Registrant’s mostrecent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of anannual report) that has materially affected, or is reasonably likely tomaterially affect, the Registrant’s internal control over financial reporting.
     5. CCC’s other certifying officer and I have disclosed, based on our mostrecent evaluation of internal control over financial reporting, to theRegistrant’s auditors and the Audit Committee of Registrant’s Board ofDirectors (or persons performing the equivalent function):
          (a) all significant deficiencies and material weaknesses in the design oroperation of internal control over financial reporting which are reasonablylikely to adversely affect the Registrant’s ability to record, process,summarize and report financial information; and
          (b) any fraud, whether or not material, that involves management or otheremployees who have a significant role in the Registrant’s internal control overfinancial reporting.
Date: August 12, 2004 /s/ JOHN KALLASJohn KallasVice President andChief Financial Officer of CCC
<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>                                     1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                           5,526
<SECURITIES>                                     1,216
<RECEIVABLES>                                    2,554
<ALLOWANCES>                                      (116)
<INVENTORY>                                      3,576
<CURRENT-ASSETS>                                12,938
<PP&E>                                          14,278
<DEPRECIATION>                                  (6,792)
<TOTAL-ASSETS>                                  21,631
<CURRENT-LIABILITIES>                            4,064
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            99
<OTHER-SE>                                      11,473
<TOTAL-LIABILITY-AND-EQUITY>                    21,631
<SALES>                                          7,965
<TOTAL-REVENUES>                                 7,965
<CGS>                                            2,819
<TOTAL-COSTS>                                    2,819
<OTHER-EXPENSES>                                 9,045
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 424
<INCOME-PRETAX>                                 (4,244)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             (4,244)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    (4,244)
<EPS-PRIMARY>                                    (0.43)
<EPS-DILUTED>                                    (0.43)
        


</TABLE>